ArticleCureus2025
Maternal Dyslipidemia and Its Association With Preterm Birth and Other Adverse Perinatal Outcomes.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The existing literature has reported a conflicting relationship between maternal dyslipidemia and preterm birth. No significant research has been performed to determine the association between maternal dyslipidemia and low birth weight (LBW), neonatal intensive care unit (NICU) stay, need for neonatal phototherapy, need for assisted ventilation, and stillbirths. This study aims to determine the association between maternal dyslipidemia and preterm births and other adverse perinatal outcomes. Methodology A total of 159 pregnant women were included in this prospective observational study. Serum lipid profile (triglycerides, total cholesterol, high-density lipoprotein, low-density lipoprotein, and very low-density lipoprotein) was tested once between 20 and 28 weeks of gestation. Mothers were followed throughout the antenatal period until delivery, and pregnancy outcomes such as preterm birth, LBW, NICU stay, need for neonatal phototherapy, need for assisted ventilation, and stillbirths were recorded in both dyslipidemic and eulipidemic women. Results In total, seven (8.8%) women with dyslipidemia had preterm birth, and five (6.3%) women with eulipidemia had preterm birth (p = 0.69). Moreover, 14 women with dyslipidemia had neonatal LBW, which was significantly higher compared to six women in the eulipidemia group (17.5% vs. 7.6%; p = 0.06). The number of women whose babies needed NICU stay was 10 (12.5%) and 1 (1.3%) in the dyslipidemia and eulipidemia groups, respectively (p = 0.005). The need for phototherapy was significantly higher in the dyslipidemia group compared to the eulipidemia group (5% vs. 0%; p = 0.045). In total, seven women in the dyslipidemia group needed neonatal assisted ventilation compared to one patient in the eulipidemia group (8.8% vs. 1.3%; p = 0.064). Conclusions Maternal dyslipidemia is not associated with increased preterm birth. However, maternal dyslipidemia is associated with a significant increase in other adverse neonatal outcomes such as LBW, increased NICU stay, and neonatal phototherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.